“…21,61,62 Early reports indicate that radiation oncologists from LMICs have increased their utilization of hypofractionated regimens since the beginning of the COVID-19 pandemic with one report from India finding that 9% of radiation oncologists had implemented hypofractionated treatments for the first time. [63][64][65][66] Similarly, multiple institutions have reported that patients on average are being treated with fewer fractions per treatment course since the beginning of the COVID-19 pandemic, suggesting increased adoption of hypofractionated treatment regimens. 67,68 Despite these recent advances in the adoption of hypofractionated radiotherapy regimens, the results of the ESTRO-GIRO survey indicate that the regions that would most benefit from the widespread adoption of hypofractionated treatments also have the lowest utilization rates.…”